(Q57714784)
Statements
Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design (English)
Robert Dipaola
Maha Hussain
Kathleen W Beekman
A Dimitrios Colevas
Rodney L Dunn